Trial intelligence / Profile preview

Dengzhan Danqi Capsule for Atherosclerotic Cerebral Infarction (Qi Deficiency and Blood Stasis) Phase 3 Trial

CTR20140297Phase 3Active

Sponsor
Dadao Longda
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Dengzhan Danqi in brain infarction, ischemic stroke, sponsored by Dadao Longda. Started Apr 2014; status: active.

02

Drugs

Dengzhan Danqi
03

Conditions

brain infarctionischemic stroke

Beyond the preview

Go deeper on CTR20140297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call